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OBJECTIVES We evaluated the effect of plaque burden modification (debulking) on the short- and
long-term clinical outcomes of patients with a totally occluded native coronary artery
undergoing successful stent deployment.
BACKGROUND Although the primary success rate of crossing a chronic totally occluded coronary artery has
improved with the development of new interventional devices and guidewires, the rate of
acute reocclusion and restenosis remains high.
METHODS The in-hospital and late clinical outcomes of 150 patients who had undergone successful
stenting of 176 chronic total occlusions were analyzed. After successful crossing of the lesion,
44 patients with 50 lesions underwent debulking by laser angioplasty, rotational or directional
atherectomy followed by stenting, whereas 106 patients with 126 lesions underwent stent
implantation without prior debulking.
RESULTS Baseline clinical and angiographic characteristics were similar for the two groups, except for
a higher incidence of left anterior descending coronary artery location and longer lesions in
the group of patients who underwent debulking prior to stenting. In-hospital mortality,
myocardial infarction and repeat angioplasty rates were similar for the two groups. At a mean
14 6 8 months follow-up time, there were no deaths in either group, and target lesion
revascularization rates were the same (16.3% in the debulking plus stent group vs. 14.4% in
the stent alone group, p 5 NS).
CONCLUSIONS Treatment of chronic total native coronary artery occlusions with stent deployment with and
without lesion modification (debulking) results in a favorable in-hospital outcome, with
relatively low long-term target lesion revascularization rates. (J Am Coll Cardiol 2000;35:
151–6) © 1999 by the American College of Cardiology
Revascularization of chronic total coronary artery occlusions
remains an important challenge in interventional cardiology.
Although the primary crossing rate has improved with the
development of new guidewires (1–4), patients with total
occlusions still have an abrupt closure rate up to 8% (5) and
a high restenosis rate (50% to 70%) after balloon angioplasty
alone (6–11).
These disappointing results can be attributed in part to
the increased plaque burden, smaller postprocedural lumen
area and larger residual cross-sectional narrowing present
after percutaneous transluminal coronary angioplasty
(PTCA) of chronic total occlusions compared with nonoc-
cluded vessels (12). These findings suggest that aggressive
plaque burden removal may improve clinical outcomes
(13,14). In addition, coronary stent implantation after
successful recanalization of chronic total occlusion has been
shown to reduce restenosis and reocclusion rates and to
improve global and regional left ventricular function com-
pared with balloon angioplasty alone (15–19). It is un-
known, however, whether plaque reduction (debulking)
before stent implantation would further improve late event-
free survival.
The purpose of this study was to examine the effect of
plaque debulking prior to stenting on the acute and late
clinical outcomes of patients undergoing percutaneous re-
vascularization of chronic total occlusions in native coronary
arteries.
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METHODS
Patient population. Between July 1996 and July 1997, a
total of 150 consecutive patients underwent successful
recanalization of 176 totally occluded native coronary arter-
ies (duration of occlusion .2 weeks). These patients repre-
sent 73% of the total number of patients with a chronic total
occlusion in whom recanalization had been attempted.
Patients were treated with either of two different strate-
gies: 1) lesion modification (debulking) by excimer laser,
rotational or directional atherectomy followed by stent
deployment in 44 patients (50 lesions), or 2) conventional
balloon angioplasty followed by stent placement in 106
patients (126 lesions). Following hospital discharge, pa-
tients were either seen at the clinic by the research nurse or
contacted by telephone or mail for late clinical follow-up.
Procedure. Device strategy was selected based on vessel
size and anatomy, preprocedural lesion configuration (i.e.,
lesion eccentricity, ulceration, irregularity, calcification,
thrombus or ostial location) and the absence of clinical
contraindications at the discretion of the operator. Debulk-
ing was achieved with excimer laser, directional coronary
atherectomy (DCA) or rotational atherectomy, as previously
described (20).
Adjunctive medical therapy. During the procedure, hep-
arin bolus was administered to achieve an activated clotting
time .300 s. Aspirin therapy, 325 mg, was started at least
24 h before the procedure and continued indefinitely.
Ticlopidine, 500 mg, was given before the procedure and
treatment with it was continued for four weeks (250 mg
orally twice daily). Glycoprotein IIb/IIIa inhibitors were
used in ,2% of the patients in both groups.
Angiographic analysis. Quantitative angiographic analysis
was done at the Angiographic Core Laboratory by an
independent observer who was unaware of the purpose or
outcome of the study. The analysis was done on end-
diastolic cine frames demonstrating the stenosis in its more
severe and nonforeshortening projection, using a computer-
assisted, automated algorithm (ARTREK, Quantitative
Cardiac Systems) and using standard morphologic criteria
(21). The contrast-filled catheter was used as the calibration
standard. Reference vessel size was assessed from the post-
procedural images.
Intravascular ultrasound. Intracoronary ultrasound
(IVUS) studies were performed after intracoronary injection
of 200 mg of nitroglycerin with one of the two commercially
available systems as previously described (22). In each case,
the transducer was advanced approximately 10 mm beyond
the lesion and withdrawn automatically at 0.5 mm/s to the
aorto-ostial junction. On-line analysis during the procedure
was reported to the operator regarding reference vessel
diameter, minimal lumen diameter (MLD), stent and lu-
men cross-sectional area and stent apposition. The images
were recorded on a 1/2-in. high-resolution S-VHS tape for
off-line analysis and independently reviewed at the IVUS
Core Laboratory.
Definitions. A “total occlusion” was defined as complete
interruption of the vessel with Thrombolysis in Myocardial
Infarction (TIMI) grade flow 0 (23). “Angiographic suc-
cess” was defined as recanalization of the artery with a
,50% residual diameter stenosis with restoration of TIMI
3 flow. Q-wave myocardial infarction (MI) was defined by
the development of new Q waves on the postprocedural
ECG. Non-Q-wave MI was defined as the elevation of
CPK-MB $5 times of normal values without the appear-
ance on new Q waves.
Statistical analysis. Statistical analysis was performed us-
ing software (StatView 4.01; Abacus Concepts; Berkeley,
California). Continuous data are presented as mean 6SD.
Comparisons between groups were performed using the
chi-square test to analyze differences in categorical variables,
and the Student t test was used for continuous variables.
Follow-up events were analyzed by the Kaplan-Meier
method. Freedom from target lesion revascularization
(TLR) and for late events was generated for both groups
and differences between them compared with the log rank
test. Cox proportional hazards regression analysis was per-
formed to determine the independent correlates of TLR and
late events. Clinical, morphologic and procedural variables
were entered into a multiple logistic regression model to
determine the following independent correlates of TLR and
event-free survival: age, gender, history of diabetes, lesion
length, ostial location, left anterior descending coronary
artery, restenotic lesion, preprocedural reference vessel di-
ameter, final MLD and final cross-sectional area (CSA).
The level of significance was p , 0.05.
RESULTS
Patient characteristics. The baseline clinical characteris-
tics for all 150 patients with 176 totally occluded native
coronary lesions who had undergone either one of the two
treatment strategies are shown in Table 1. Mean age was
59 6 12 years (range, 30 to 88 years), and 113 (75.8%) were
male. The group undergoing debulking before stenting
included more male patients, with a higher, but not signif-
Abbreviations and Acronyms
CSA 5 cross-sectional area
DCA 5 directional coronary atherectomy
IVUS 5 intravascular ultrasound
LAD 5 left anterior descending artery
MI 5 myocardial infarction
MLD 5 minimal lumen diameter
PTCA 5 percutaneous transluminal coronary
angioplasty
TIMI 5 Thrombolysis in Myocardial Infarction
TLR 5 target lesion revascularization
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icant, number of diabetic patients and patients who had
undergone aortocoronary bypass surgery. Accelerated an-
gina was present in 66.7% of patients who had undergone
stenting and in 68.2% of patients who had undergone
debulking prior to stenting (p 5 NS), whereas recurrent
angina after an MI was present in 15.7% and 11.4%,
respectively (p 5 NS).
Revascularization strategies. Debulking was performed
prior to stenting in 44 patients with 50 lesions. Excimer
laser was used in 34 lesions (68%), rotational atherectomy in
10 lesions (19%) and directional atherectomy in 6 lesions
(13%). Stent alone was used in 106 patients with 126
lesions. A single stent was deployed in 47 patients (31%), 2
stents in 56 patients (37%) and .3 stents in 47 patients
(31%). An average of 2.03 6 1.06 stents were used in each
patient.
Angiographic and IVUS characteristics. Intravascular ul-
trasound was performed in 86.1% of the lesions after
successful recanalization of the artery and at the end of the
procedure. The angiographic and IVUS characteristics for
these lesions are detailed in Table 2. The left anterior
descending artery (LAD) was the target vessel in 50% of the
patients who had undergone debulking with stent deploy-
ment, compared with 21% in the other group (p 5 0.001).
These patients also had longer lesions than the patients who
had undergone stenting alone (10.4 6 6.5 mm vs. 23.0 6
14.1 mm, p 5 0.03). Postrecanalization, prestenting refer-
ence vessel diameter, preprocedural lesion CSA, final lumen
CSA and final MLD were slightly larger in patients who
had undergone stenting alone, although the differences were
not statistically significant (Table 2).
In-hospital events. Clinical events during hospitalization
are presented in Table 3. Death, Q-wave and non Q-wave
MI rates did not differ significantly between the two groups.
Major vascular complications requiring surgical repair or
blood transfusion were also similar between the groups.
Clinical follow-up. Data were available for 98% of the
patients, at mean follow-up time of 14 6 8 months (Table
4). There were no deaths during this period in either of the
two groups. There was a higher incidence of Q-wave MI in
the debulking plus stent group compared with the stent
alone group (7% vs. 0%, p 5 0.02). The incidence of TLR
was similar for both groups respectively (16.4% vs. 14.4%,
p 5 NS). By Cox regression analysis, age was identified as
the only independent predictor of TLR (odds ratio: 0.958;
confidence interval, 0.93 to 0.98, p 5 0.0008).
DISCUSSION
Despite improvements in the rate of recanalization of
chronic total occlusions, there is still a 7% to 8% risk of
acute reocclusion (5,18) and a 50% to 70% rate of six-month
restenosis after balloon angioplasty (5–11,24–27). These
suboptimal results can be attributed to the increased plaque
burden, a smaller postprocedural lumen area and a larger
residual percentage of cross-sectional narrowing present in
chronic total occlusions compared with nonoccluded vessels
after angioplasty (12).
Early reports suggested that stenting of chronic total
occlusions might reduce the rates of early reocclusion and
restenosis (12,15,16,28). These data have been confirmed by
recently published randomized, controlled trials (16–19).
However, restenosis rates are still high after stenting of
chronic total occlusions with reported rates of 22% to 32%
(16–18). Plaque debulking prior to stenting may render
additional benefits by removing the increased plaque burden
seen in this type of lesion and also allow for the successful
treatment of lesions that would be inadequately treated with
stent alone. However, to our knowledge, the outcome of
debulking prior to stenting in chronic total occlusions has
not been studied previously.
The present study analyzed the in-hospital and long-term
outcome of all patients in our institution who had under-
gone successful recanalization of chronic totally occluded
native coronary arteries over a one-year period and were
treated either by debulking plus stent or by stenting alone.
Both groups of patients had similar baseline clinical and
angiographic characteristics, except for a higher incidence of
male patients with longer lesions located more frequently in
the LAD distribution in the group of patients who had
undergone debulking prior to stenting. Reference vessel size
and final lumen dimensions were similar between the
groups. This is important in light of previous studies that
showed that the benefit from stenting after PTCA of a
chronic total occlusion is derived from the larger final lumen
achieved with this strategy when compared with PTCA
alone (19). Importantly, in-hospital outcomes were similar









Age, yr 58 6 12 59 6 10 NS
Male gender 70.8% 88.4% 0.02
Prior infarction 59.3% 44.2% 0.09
Prior CABG 13.0% 25.0% 0.07
Prior PTCA 40.2% 34.9% NS
Hypertension 68.5% 52.3% 0.06
Diabetes mellitus 18.5% 27.3% 0.07
Hyperlipidemia 68.5% 65.9% NS
Accelerated angina 66.7% 68.2% NS
Ejection fraction 0.47 6 0.12 0.49 6 0.11 NS
Restenotic lesion 16.8% 14.6% NS
Target vessel
Left main 0.8% 2.0% NS
LAD 21.4% 50.0% 0.001
Left circumflex 23.8% 10.0% 0.04
Right coronary 54.0% 38.0% 0.06
*NS 5 p . 0.10. CABG 5 coronary artery bypass surgery; PTCA 5 percutaneous
transluminal coronary angioplasty.
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between both groups with low death rates (,1%), Q-wave
MI (,3%), repeat PTCA (5% to 7%) and major vascular
complications (7%). Although the incidence of CPK-MB
elevation $5 3 normal was frequent in both groups (13.6%
vs. 19.6%, p 5 NS), there was no increase in either
short-term or long-term mortality in either one of the
groups.
In the present study, the debulking devices included 68%
excimer laser and 19% rotational atherectomy. We do not
believe there is a significant difference in restenosis rates
among the various ablation devices in the studied setting. In
the recently published results of the ERBAC trial, excimer
laser angioplasty and rotational atherectomy had similar
clinical outcomes and restenosis rates for the treatment of
complex coronary lesions (29).
During long-term follow-up, there was no difference in
death (0%) or TLR rates (14.4% vs. 16.3%, p 5 NS) between
the two groups. There was a higher incidence of late Q-wave
MI in the group of patients who had undergone debulking and
stent deployment.










Angiographic success 97.1% 100% NS
Ostial lesion 5.0% 6.1% NS
Lesion length (mm) 10.4 6 4.0 23.0 6 5.1 0.03
Calcification 48.7% 37.5% NS
Dissection (post) 9.02% 12.5% NS
Abrupt closure 1.6% 2.0% NS
Reference lumen (pre)
(mm)
2.96 6 0.57 3.03 6 0.37 NS
Reference lumen
(final) (mm)
2.98 6 0.58 3.11 6 0.42 NS
Final MLD (mm) 2.62 6 0.66 2.70 6 0.62 NS
Final percent stenosis 11.9 6 15.5 13.1 6 17.6 NS






8.85 6 3.6 7.91 6 2.8 NS
Reference lumen (final)
CSA (mm2)
8.97 6 4.3 8.06 6 3.2 NS
Preprocedural lesion
CSA (mm2)
1.47 6 0.6 1.27 6 0.6 NS
Final lumen CSA
(mm2)
6.67 6 2.5 6.38 6 0.7 NS
Final MLD (mm) 2.58 6 0.4 2.56 6 0.2 NS
*NS 5 p . 0.10; CSA 5 cross-sectional area; IVUS 5 intravascular ultrasound; MLD 5 minimal lumen diameter; TIMI 5
Thrombolysis in Myocardial Infarction (23).








Q-wave MI 2.8% 2.3%
Non-Q-wave MI 19.6% 13.6%
Repeat PTCA 4.6% 6.8%
Emergency CABG 2.8% 0%
Major vascular complication 7.4% 6.8%
*p 5 NS for all values; CABG 5 coronary artery bypass graft surgery; MI 5
myocardial infarction; PTCA 5 percutaneous transluminal coronary angioplasty.









Any event 19.6% 25.6% NS




Any TLR 14.4% 16.3% NS
Any PTCA 10.2% 14.3% NS
Any CABG 5.1% 4.7% NS
*NS 5 p . 0.10; CABG 5 coronary artery bypass graft surgery; PTCA 5
percutaneous transluminal coronary angioplasty; TLR 5 target lesion revasculariza-
tion.
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Thus, debulking plus stent deployment achieved similar
TLR rates when compared with stent alone, despite the
higher frequency of longer lesions and LAD location,
characteristics that have been associated with an increased
incidence of in-stent restenosis (30–32). These results may
convey the appropriate selection of a debulking strategy
after successful recanalization of such lesions. However,
neither one of these factors nor debulking prior to stenting
was an independent predictor of TLR or decreased event-
free survival when analyzed in a statistical model; age was
the sole independent predictor of TLR.
Study limitations. The present study was a retrospective
analysis, and therefore the conclusions and results are
subject to the limitations inherent in all such reports.
Operator evaluation of each individual case, the selection of
debulking before stent deployment and the specific device
used may be important limitations. Patients did not undergo
routine follow-up catheterization to assess the angiographic
restenosis rate and early reocclusion rate, which has been
shown to be high and may be clinically silent because of
preexisting collateral flow (19). However, we found an
encouraging relatively low rate of clinical restenosis for a
population of patients in whom results have been discour-
aging in the past with balloon angioplasty alone (31,32).
Application of a debulking strategy was implemented with-
out a protocol to dictate a specific reduction in plaque
burden. Thus, we did not necessarily evaluate “optimal” (or
“maximal”) debulking in this study. It is unknown whether
debulking with high ablation efficiency in this type of lesions
might yield even better results. Finally, the small study
population may not allow for appropriate correction of
baseline imbalances between the groups. This may have
introduced a bias against the debulking plus stent approach,
as this group included longer and more LAD lesions.
CONCLUSIONS
Treatment of chronic total native coronary artery occlusions
with stent deployment with or without debulking results in
favorable short- and long-term clinical outcomes. The TLR
rates were similar in the two strategies, indicating the
success of plaque burden reduction prior to stenting in
longer and LAD lesions. A prospective randomized study
should evaluate more aggressive “optimal” debulking prior
to stenting for the treatment of totally occluded native
coronary arteries.
Reprint requests and correspondence: Dr. Mehran, Director,
Clinical Research and Data Coordinating Center, Cardiovascular
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